Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January-September 2008. The presentation will be held in Swedish.

Time: Wednesday, October 22, 2008 at 3.00 p.m. CET.
Telephone number: +46 8 505 201 10
Conference name: Vitrolife

Vitrolife participants:
Magnus Nilsson, CEO
Anna Ahlberg, CFO

The press release for Vitrolife’s interim report will be released in good time before 3.00 p.m. CET on October 22.

Before the conference call, slides will be available at the company web page, www.vitrolife.com, under the section Investors/News (the Swedish page).

A recorded version of the presentation will be available for seven days on number +46 8 505 203 33, access code 813897.











Queries should be addressed to:
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Subscribe

Documents & Links